Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5153]

Part 1: When to test

PARP inhibition in the treatment of prostate cancer

Part 1: When to test ( PARP inhibition in the treatment of prostate cancer )

Part 2: Who to test

PARP inhibition in the treatment of prostate cancer

Part 2: Who to test ( PARP inhibition in the treatment of prostate cancer )

Part 3: How to test

PARP inhibition in the treatment of prostate cancer

Part 3: How to test ( PARP inhibition in the treatment of prostate cancer )

Part 4: Metastatic prostate cancer and HRR defects

PARP inhibition in the treatment of prostate cancer

Part 4: Metastatic prostate cancer and HRR defects ( PARP inhibition in the treatment of prostate cancer )

Part 5: BRCA 1/2 mutations and prostate cancer

PARP inhibition in the treatment of prostate cancer

Part 5: BRCA 1/2 mutations and prostate cancer ( PARP inhibition in the treatment of prostate cancer )

The role of testing in prostate cancer treatment

Prof Phil Cornford, Dr Joaquin Mateo, Prof Alex Wyatt and Prof Derya Tilki

The role of testing in prostate cancer treatment ( Prof Phil Cornford, Dr Joaquin Mateo, Prof Alex Wyatt and Prof Derya Tilki )

Prostate cancer screening using prostate-specific antigen, a multiplex blood...

Prof Martin Eklund - Karolinska Institutet, Solna, Sweden

Prostate cancer screening using prostate-specific antigen, a multiplex blood-test, MRI and targeted prostate biopsies ( Prof Martin Eklund - Karolinska Institutet, Solna, Sweden )

OncoAlert and ecancer weekly round up for July 12- July 18, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly round up for July 12- July 18, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

Unmet medical needs and emerging data on EGFR exon 20 insertion mutation NSCLC...

Prof Caicun Zhou - Shanghai Pulmonary Hospital, Shanghai, China

Unmet medical needs and emerging data on EGFR exon 20 insertion mutation NSCLC at ASCO 2021 ( Prof Caicun Zhou - Shanghai Pulmonary Hospital, Shanghai, China )

Cell free DNA BRAF mutant allele fraction and whole exome sequencing in...

Dr Elena Elez - Vall d'Hebron University Hospital, Barcelona, Spain

$Cell free DNA BRAF mutant allele fraction and whole exome sequencing in BRAFV600E metastatic colorectal cancer ( Dr Elena Elez - Vall d'Hebron University Hospital, Barcelona, Spain )$

ZUMA-3: KTE-X19, an anti-CD19 chimeric antigen receptor T-cell therapy for R/R...

Dr Bijal Shah - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA

ZUMA-3: KTE-X19, an anti-CD19 chimeric antigen receptor T-cell therapy for R/R B-cell acute lymphoblastic leukaemia ( Dr Bijal Shah - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA )

Study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab...

Dr Zev Wainberg - University of California Los Angeles, California, USA

Study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in patients with metastatic oesophageal cancer ( Dr Zev Wainberg - University of California Los Angeles, California, USA )

More from ecancer